abstract |
The present invention provides a novel crystalline form of 2,3-dimethyl-8- (2,6-dimethylbenzylamino) -N-hydroxyethyl-imidazo [1,2-a] pyridine-6-carboxamide mesylate salt and It is about the mixture. Furthermore, the present invention also relates to methods for obtaining them, the use of the compounds for the treatment of gastrointestinal diseases, and pharmaceutical compositions comprising them. |